Back to all substances
Ipamorelin
Also known as: IPAM
Growth Hormone Secretagogue
PeptideT2Partial ProfilePeptide
C
Tier C
Single RCT or lower-quality studies
Selective growth hormone secretagogue with minimal side effects. Promotes deep sleep, recovery, and improved body composition.
Mechanism of Action
Mimics ghrelin at the GH secretagogue receptor. Stimulates pulsatile GH release from pituitary. More selective than GHRP-6.
Contraindications
- Cancer history (growth hormone concerns)
- Diabetes (may affect insulin sensitivity)
- Research chemical - not FDA approved
Performance Profile
Sleep Quality
+4
Sleep Onset
+2
Deep Sleep
+4
Recovery Speed
+4
Dosage
100mcg
min
200mcg
300mcg
max
Timing
Best time
Evening
30 min
onset
4 hr
duration
Half-life
2 hrSafety & Legal
7/10
Generally safe
Legal Status
Unregulated
Mild
Moderate
Severe
Injection site reaction
1-10%mild
Water retention
0.1-1%mild
Numbness/tingling
0.1-1%mild
Increased hunger
0.1-1%mild